# Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma

> **NCT02633514** · PHASE3 · WITHDRAWN · sponsor: **Fudan University**

## Conditions studied

- Thymoma and Thymic Carcinoma

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Etoposide
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT02633514
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-01
- **Primary completion:** 2024-12
- **Final completion:** 2026-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02633514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02633514, "Adjuvant Treatment for Incomplete Resection Thymoma or Thymic Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02633514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*